Evidence map›Paper›PMID 37770274›Full record

ArticleBMJ open2023

ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis.

Uyen Koh, Anne E Cust, Pablo Fernández-Peñas, Graham Mann, Rachael Morton, Rory Wolfe, Elizabeth Payne, Caitlin Horsham, Grace Kwaan, Rashidul Alam Mahumud and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Nevi and Melanoma.Hematology/oncology clinics of North America · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Uyen KohFrazer Institute, Dermatology Research Centre, The University of Queensland, Brisbane, Queensland, Australia u.koh@uq.edu.au.ORCID 0000-0002-8032-0244
Anne E CustThe Daffodil Centre (A Joint Venture with Cancer Council NSW), The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-5331-6370
Pablo Fernández-PeñasWestmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-4882-1564
Graham MannMelanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Rachael MortonNHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Rory WolfeSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0002-2126-1045
Elizabeth PayneFrazer Institute, Dermatology Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
Caitlin HorshamCentre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Grace KwaanWestmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Rashidul Alam MahumudNHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Maithili SashindranathSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Hans Peter SoyerFrazer Institute, Dermatology Research Centre, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-4770-561X
Victoria MarVictorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia.
Monika JandaCentre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-1728-8085
The University of Queensland · AUThe University of Sydney · AUMonash University · AUAlfred Health · AUAustralian National University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThree-dimensional (3D) total body photography may improve early detection of melanoma and facilitate surveillance, leading to better prognosis and lower healthcare costs. The Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID) cohort study will assess long-term outcomes from delivery of a precision strategy of monitoring skin lesions using skin surface imaging technology embedded into health services across Australia. METHODS AND ANALYSIS: A prospective cohort study will enrol 15 000 participants aged 18 years and above, across 15 Australian sites. Participants will attend study visits according to their melanoma risk category: very high risk, high risk or low/average risk, every 6, 12 and 24 months, respectively, over 3 years. Participants will undergo 3D total body photography and dermoscopy imaging at study visits. A baseline questionnaire will be administered to collect sociodemographic, phenotypic, quality of life and sun behaviour data. A follow-up questionnaire will be administered every 12 months to obtain changes in sun behaviour and quality of life. A saliva sample will be collected at the baseline visit from a subsample. ETHICS AND DISSEMINATION: The ACEMID cohort study was approved by the Metro South Health Human Research Ethics Committee (approval number: HREC/2019/QMS/57206) and the University of Queensland Human Research Ethics Committee (approval number: 2019003077). The findings will be reported through peer-reviewed and lay publications and presentations at conferences. TRIAL REGISTRATION NUMBER: ACTRN12619001706167.

Indexed as

MelanomaQuality of LifeAustraliaCohort StudiesHumansPhotographyProspective StudiesAdult dermatologyDERMATOLOGYDermatopathologyEpidemiologyPUBLIC HEALTH

Identifiers

PMID37770274
PMCPMC10546123
OpenAlexW4387143115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.